MUNICH, March 6, 2015 /PRNewswire/ --
Cutting-edge device contains a new, clinically proven, algorithm specifically designed to treat female specific sleep disordered breathing[2]
To coincide with International Women's Day 2015 (Mar, 8. 2015), ResMed - a world leader in the development of innovative technologies to treat sleep-related disorders - has announced the European launch of the AirSense 10 AutoSet for Her, the first range of treatments designed to provide an integrated sleep solution specifically for women living with obstructive sleep apnoea (OSA).
(Logo: http://photos.prnewswire.com/prnh/20150306/732794-a )
(Photo: http://photos.prnewswire.com/prnh/20150306/732794-b )
Sleep apnoea is a debilitating disorder affecting many thousands of women:
The symptoms of sleep apnoea present differently in women than men and include insomnia, restless legs, fatigue/daytime sleepiness, depression, headaches and muscle pain,[5] and the risk of sleep apnoea may worsen in women during pregnancy[6] and after menopause due to hormonal changes in the body[7]. Women with untreated sleep apnoea are more likely to be diagnosed with diabetes and cardiovascular diseases than women without sleep apnoea,[8] and severe sleep apnoea has been associated with cardiovascular death in women.[9] There are a number of significant gender-related differences in the symptoms and diagnosis of sleep apnoea and such differences require a tailored treatment approach.
Identifying the impact of sleep apnoea on women as an area of high unmet medical need, ResMed has designed a completely integrated sleep solution delivering tailored therapy choices specifically for women. The ResMed Air Solutions connected care platform is an ecosystem of hardware and software solutions designed to improve overall patient care and streamline compliance monitoring and therapy management. Featuring built-in wireless connectivity and advanced comfort technologies, the AutoSet for Her delivers a unique, clinically proven,[2] auto-adjusting algorithm designed to treat mild-to-moderate sleep apnoea in women. To complement the AirSense 10 AutoSet for Her device, is the newly launched range of ultra-light and compact masks, the AirFit for Her offering the perfect fit tailored to the female anatomy.
"Sleep apnoea in women is a serious and growing health concern which needs addressing. In some of our markets where diagnostics require several nights in a laboratory, we observe many discouraged women dropping out before getting tested" said Anne Reiser, ResMed president Europe Asia Pacific. "With so many women now living with sleep apnoea, and many more cases going undiagnosed, we have developed a sleep solution specifically designed for female patients living with this debilitating condition. To coincide with International Women's Day, our range of innovative solutions is now available in many European markets, with the goal of helping women to claim back their lost sleep and get on with their daily lives".
For more information visit resmed.com
About ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit http://www.resmed.com
About obstructive sleep apnoea
Obstructive sleep apnoea is a serious condition where the muscles in the throat relax during sleep, causing the sufferer to temporarily stop breathing. If untreated it can occur hundreds of times a night and lead to daytime fatigue as well as more serious health problems.
Sleep apnoea can affect women and men at any age, with or without any other contributing conditions and is often associated with serious conditions such as high blood pressure, diabetes, obesity, heart failure and stroke. However, effective treatment can help reduce the risk of chronic diseases and other comorbidities.
References
1. Heinzer R., et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. The Lancet Respir Med 2015; Published Online February 12, 2015 http://dx.doi.org/10.1016/S2213-2600(15)00043-0
2. McArdle N., et al. Study Of A Novel Automatic Positive Airway Pressure Algorithm For The Treatment Of Obstructive Sleep Apnoea In Women, American Thoracic Society Annual Congress, San Diego 2014: A5621
3. Franklin K.A., et al. Sleep apnoea is a common occurrence in females. Eur Respir J 2013; 3:610-5
4. Young T., et al. The occurrence of sleep-disordered breathing among middle-aged adults. NEJM 1993; 328: 1230-1235
5. Valipour A., et al. Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire. Sleep 2007; 30(3): 312-9
6. Chakradhar V and Saiprakash BV. Sleep-Disordered Breathing During Pregnancy. J Am Board Fam Med 2009; 22:158-168
7. Eichling PS and Sachni J. Menopause related sleep disorders. J Clin Sleep Med 2005; 1(3): 291-300
8. Greenberg-Dotan S. et al. Gender differences in morbidity and health care utilization among adult obstructive sleep apnoea patients. Sleep 2007;
30:1173-80
9. Campos-Rodriguez F. et al. Cardiovascular mortality in women with OSA with or without CPAP treatment- A cohort study. Ann Intern Med 2012;
156:115-22
Share this article